Auxly Cannabis Correlations
| XLY Stock | CAD 0.03 0.01 14.29% |
The current 90-days correlation between Auxly Cannabis Group and Decibel Cannabis is 0.01 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Auxly Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Auxly Cannabis Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Auxly Cannabis Correlation With Market
Good diversification
The correlation between Auxly Cannabis Group and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Auxly Cannabis Group and DJI in the same portfolio, assuming nothing else is changed.
Auxly |
The ability to find closely correlated positions to Auxly Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Auxly Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Auxly Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Auxly Cannabis Group to buy it.
Moving against Auxly Stock
| 0.6 | BRY | Bri Chem Corp | PairCorr |
| 0.53 | SEC | Senvest Capital | PairCorr |
| 0.53 | ERE-UN | European Residential Real | PairCorr |
| 0.51 | AAPL | Apple Inc CDR | PairCorr |
| 0.5 | LB | Laurentian Bank | PairCorr |
| 0.48 | PRU | Perseus Mining | PairCorr |
| 0.47 | FFH-PH | Fairfax Financial | PairCorr |
| 0.44 | NPTH | NeuPath Health | PairCorr |
| 0.43 | Y | Yellow Pages Limited | PairCorr |
| 0.4 | NICU | Magna Mining | PairCorr |
| 0.37 | VLE | Valeura Energy | PairCorr |
| 0.35 | FFH-PC | Fairfax Fin Hld | PairCorr |
| 0.34 | FFH | Fairfax Financial | PairCorr |
| 0.33 | BMO | Bank of Montreal | PairCorr |
| 0.62 | DBO | D Box Technologies | PairCorr |
| 0.57 | AQN-PD | Algonquin Power Utilities | PairCorr |
| 0.52 | TCS | TECSYS Inc | PairCorr |
| 0.47 | FFH-PF | Fairfax Financial | PairCorr |
| 0.47 | ENB-PH | Enbridge H Cum | PairCorr |
| 0.45 | OM | Osisko Metals | PairCorr |
| 0.45 | ENS-PA | E Split Corp | PairCorr |
| 0.44 | QNC | Quantum Numbers | PairCorr |
| 0.35 | XX | Avante Logixx | PairCorr |
| 0.34 | CRM | SalesforceCom CDR | PairCorr |
| 0.32 | ARX | ARC Resources | PairCorr |
| 0.32 | HUT | Hut 8 Mining | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Auxly Stock performing well and Auxly Cannabis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Auxly Cannabis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DB | 4.32 | 0.24 | 0.02 | 2.72 | 4.95 | 14.29 | 39.08 | |||
| LOVE | 4.29 | 0.35 | 0.05 | 3.59 | 4.86 | 12.86 | 33.46 | |||
| XHB | 0.22 | 0.02 | 0.00 | 0.13 | 0.11 | 0.51 | 1.52 | |||
| ALA-PA | 0.50 | 0.08 | 0.08 | 0.49 | 0.57 | 1.15 | 3.73 | |||
| ERE-UN | 1.21 | 0.23 | 0.18 | 0.17 | 1.04 | 2.30 | 20.23 | |||
| CLU | 0.47 | 0.00 | (0.01) | 0.02 | 0.56 | 1.02 | 5.88 | |||
| RUDB | 0.26 | 0.06 | 0.07 | (0.52) | 0.24 | 0.70 | 1.96 | |||
| BN-PFI | 0.50 | 0.05 | 0.04 | (3.88) | 0.53 | 1.10 | 2.73 | |||
| XEG | 1.14 | (0.06) | 0.00 | (2.42) | 0.00 | 2.20 | 8.20 | |||
| SOLI-P | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Auxly Cannabis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Auxly Cannabis Corporate Management
Elected by the shareholders, the Auxly Cannabis' board of directors comprises two types of representatives: Auxly Cannabis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Auxly. The board's role is to monitor Auxly Cannabis' management team and ensure that shareholders' interests are well served. Auxly Cannabis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Auxly Cannabis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ian Rapsey | Chief Officer | Profile | |
| Ron Fichter | General Secretary | Profile | |
| Hugo Alves | CEO Director | Profile | |
| Vladimir Klacar | Senior Planning | Profile | |
| Alan Cooke | VP Operations | Profile | |
| Brian Schmitt | Chief Officer | Profile | |
| Kevin Furet | Chief Officer | Profile |